Literature DB >> 23812338

Research to inform the consent-to-research process.

Damon C Scales.   

Abstract

Mesh:

Year:  2013        PMID: 23812338     DOI: 10.1007/s00134-013-2990-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  24 in total

1.  Obtaining consent for research studies on incompetent subjects: the Quebec experience.

Authors:  Sheldon Magder; Annette Lefebvre
Journal:  Intensive Care Med       Date:  2003-02-11       Impact factor: 17.440

2.  Considering the vulnerabilities of surrogate decision-makers when obtaining consent for critical care research.

Authors:  Kali A Barrett; Damon C Scales
Journal:  Intensive Care Med       Date:  2011-11-26       Impact factor: 17.440

3.  Why substitute decision makers provide or decline consent for ICU research studies: a questionnaire study.

Authors:  Sangeeta Mehta; Friederike Quittnat Pelletier; Maedean Brown; Cheryl Ethier; David Wells; Lisa Burry; Rod MacDonald
Journal:  Intensive Care Med       Date:  2011-11-26       Impact factor: 17.440

4.  Research ethics board approval for an international thromboprophylaxis trial.

Authors:  Kristina Lutz; Kelly Wilton; Nicole Zytaruk; Lisa Julien; Richard Hall; Johanne Harvey; Yoanna Skrobik; Nicholas Vlahakis; Laurie Meade; Andrea Matte; Maureen Meade; Karen Burns; Martin Albert; Bronwyn Barlow Cash; Shirley Vallance; James Klinger; Diane Heels-Ansdell; Deborah Cook
Journal:  J Crit Care       Date:  2012-02-04       Impact factor: 3.425

Review 5.  Informed consent for research purposes in intensive care patients in Europe--part I. An official statement of the European Society of Intensive Care Medicine. Working Group on Ethics.

Authors:  F Lemaire; L Blanch; S L Cohen; C Sprung
Journal:  Intensive Care Med       Date:  1997-03       Impact factor: 17.440

6.  Informed consent and SUPPORT.

Authors:  Jeffrey M Drazen; Caren G Solomon; Michael F Greene
Journal:  N Engl J Med       Date:  2013-04-17       Impact factor: 91.245

7.  Surrogate decision makers' attitudes towards research decision making for critically ill patients.

Authors:  Kali A Barrett; Niall D Ferguson; Valerie Athaide; Deborah J Cook; Jan O Friedrich; Ellen McDonald; Ruxandra Pinto; Orla M Smith; James Stevenson; Damon C Scales
Journal:  Intensive Care Med       Date:  2012-07-24       Impact factor: 17.440

8.  Attitudes of the general public toward alternative consent models.

Authors:  Karen E A Burns; Nora M Magyarody; Mark Duffett; Rosane Nisenbaum; Deborah J Cook
Journal:  Am J Crit Care       Date:  2010-04-08       Impact factor: 2.228

9.  Research participants' opinions of delayed consent for a randomised controlled trial of glucose control in intensive care.

Authors:  J E Potter; S McKinley; A Delaney
Journal:  Intensive Care Med       Date:  2012-10-25       Impact factor: 17.440

10.  When is informed consent required in cluster randomized trials in health research?

Authors:  Andrew D McRae; Charles Weijer; Ariella Binik; Jeremy M Grimshaw; Robert Boruch; Jamie C Brehaut; Allan Donner; Martin P Eccles; Raphael Saginur; Angela White; Monica Taljaard
Journal:  Trials       Date:  2011-09-09       Impact factor: 2.279

View more
  4 in total

1.  Outcomes and statistical power in adult critical care randomized trials.

Authors:  Michael O Harhay; Jason Wagner; Sarah J Ratcliffe; Rachel S Bronheim; Anand Gopal; Sydney Green; Elizabeth Cooney; Mark E Mikkelsen; Meeta Prasad Kerlin; Dylan S Small; Scott D Halpern
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

2.  Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial.

Authors:  Nick Daneman; Asgar H Rishu; Wei Xiong; Sean M Bagshaw; Deborah J Cook; Peter Dodek; Richard Hall; Anand Kumar; Francois Lamontagne; Francois Lauzier; John C Marshall; Claudio M Martin; Lauralyn McIntyre; John Muscedere; Steven Reynolds; Henry T Stelfox; Robert A Fowler
Journal:  Trials       Date:  2015-04-18       Impact factor: 2.279

3.  Low-chloride versus high-chloride hypertonic solution for the treatment of subarachnoid hemorrhage-related complications (The ACETatE trial): study protocol for a pilot randomized controlled trial.

Authors:  Ofer Sadan; Owen Samuels; William H Asbury; John J Hanfelt; Kai Singbartl
Journal:  Trials       Date:  2018-11-14       Impact factor: 2.279

4.  Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) randomised clinical trial: study protocol.

Authors:  Nick Daneman; Asgar H Rishu; Ruxandra L Pinto; Yaseen M Arabi; Deborah J Cook; Richard Hall; Shay McGuinness; John Muscedere; Rachael Parke; Steven Reynolds; Benjamin Rogers; Yahya Shehabi; Robert A Fowler
Journal:  BMJ Open       Date:  2020-05-11       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.